SPECIFIC SERUM IMMUNOGLOBULIN G TO CHLAMYDIA PNEUMONIAE IN HEALTHY CHILDREN AND ADULTS (SOUTH-EAST OF IRAN)
AbstractBackground: Chlamydia pneumoniae (C. pneumonia) is an obligate intracellular bacterium and recognized as a risk factor for several diseases such as asthma, atherosclerosis and arthritis. The aim of this study was to determine the sero-prevalence of C. pneumonia in healthy subjects in different age groups. Methods: The serum levels of anti C. pneumonia IgG were measured by using of ELISA. Results: Totally, 630 subjects (164 children and 466 adults) were included into study. The sero-prevalence and the mean titer of anti C. pneumonia antibody were 11.3% and 14.48±2.18 RU/mL; at age ≤10 years, 15% and 17.47±2.40 RU/mL at age 11–20 years, 21% and 25.15±4.56 RU/mL at age 21–30 years group, 40% and 53.77±6.40 RU/mL at age 31–40 years, 94% and 146.41±8.95 RU/mL at age 41–50 years, 98% and 153.59±10.38 RU/mL at age 51–60 years, 96% and 138.80±12.78 RU/mL at age 61–70 years, respectively. The differences of the sero-prevalence and the mean titer of anti C. pneumonia antibody between age groups were significant (p<0.0001). The sero-prevalence and the mean titer of anti C. pneumonia antibody were 11.6% and 14.33 ± 1.49 RU/mL in children and 65.5% and 97.40±4.46 RU/mL in adults. The sero-prevalence and the mean titer of anti C. pneumonia antibody were significantly higher in adults in comparison with those in children (p<0.0001). Conclusion: These findings showed that the sero-prevalence and titer of anti C. pneumonia IgG were increased with advanced ages and were higher in adults as compared to children. Keywords: Chlamydia pneumonia; IgG; Sero-prevalence; Age; Adults; Children; Iran
Villegas E, Sorlozano A, Gutierrez J. Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives. J Med Microbiol 2010;59 (11):1267–74.
Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer 2011;47(5):742–7.
Tang LF, Wang DF, Cao LQ, Wu XD, Lu J, Yu FF. [Correlation between Chlamydia pneumoniae infection and chronic obstructive pulmonary disease]. Zhonghua Liu Xing Bing Xue Za Zhi 2012;33(10):1072–4.
Awasthi S, Yadav KK, Agarwal J. Chlamydia pneumoniae infection associated with uncontrolled asthma: a hospital based cross sectional study. Indian J Pediatr 2012; 79(10):1318–22.
Lu Q, Xu J, Liu H. Association between Chlamydia pneumoniae IgG antibodies and migraine. J Headache Pain 2009;10(2):121–4.
Shima K, Kuhlenbaumer G, Rupp J. Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember? Med Microbiol Immunol 2010;199(4):283–9.
Di Pietro M, Schiavoni G, Sessa V, Pallotta F, Costanzo G, Sessa R. Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor? Osteoporos Int 2013;24(5):1677–82.
Roulis E, Polkinghorne A, Timms P. Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol 2013;21(3):120–8.
Jafarzadeh A, Esmaeeli-Nadimi A, Shariati M. High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease. Iran J Immunol 2008;5(1):51–6.
Kumar S, Hammerschlag MR. Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods. Clin Infect Dis 2007;44(4):568–76.
Blasi F, Tarsia P, Aliberti S, Cosentini R, Allegra L. Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Crit Care Med 2005;26(6):617–24.
Kanamoto Y, Ouchi K, Mizui M, Ushio M, Usui T. Prevalence of antibody to Chlamydia pneumoniae TWAR in Japan. J Clin Microbiol 1991;29(4):816–8.
Aldous MB, Grayston JT, Wang SP, Foy HM. Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979. J Infect Dis 1992;166(3):646–9.
Al-Younes HM. High prevalence of Chlamydia pneumoniae infection in an asymptomatic Jordanian population. J Microbiol Immunol Infect 2014;47(5):412–7.
Cui J, Yan W, Ni A, Kong L, Chen L. [Detection of serum Chlamydia pneumoniae antibodies and analysis of epidemiologic data in 5 years]. Zhonghua Yi Xue Za Zhi 2014;94(12):919–23.
Koh WP, Taylor MB, Hughes K, Chew SK, Fong CW, Phoon MC, et al. Sero-prevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore. Int J Epidemiol. 2002;31(5):1001–7
Lin TM, Kuo CC, Chen WJ, Lin FJ, Eng HL. Sero-prevalence of Chlamydia pneumoniae infection in Taiwan. J Infect 2004;48(1):91–5.
Paldanius M, Bloigu A, Alho M, Leinonen M, Saikku P. Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland. Clin Diagn Lab Immunol 2005;12(5):654–9.
Choi TY, Kim DA, Kim SK, Kang JO, Park SS, Jung SR. Prevalence of specific antibodies to Chlamydia pneumoniae in Korea. J Clin Microbiol 1998;36(11):342–8.
Sidal M, Kilic A, Unuvar E, Oguz F, Onel M, Agacfidan A, et al. Frequency of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in children. J Trop Pediatr 2007;53(4):225–31.